External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Infectious Disease Influenza Virus Infection

Influenza Virus Infection

What's new

Sign up or login to unlock the full suite of MEDICALLY features
Oct 15 / Roche
Stop the flu going viral: the benefits of antivirals for patients, households and communities
This symposium provides an overview of the latest evidence from clinical studies and real-word settings for the treatment, prevention and reduction of the transmission of influenza with baloxavir marboxil▼ and to discuss the potential impact on patients, households and communities.
Infectious Disease Influenza Virus Infection OPTIONS-2024

Sign up or login to unlock the full suite of MEDICALLY features
Oct 15 / Roche
Communities: impact of reduced transmission on epidemics and pandemics
This symposium provides an overview of the latest evidence from clinical studies and real-word settings for the treatment, prevention and reduction of the transmission of influenza with baloxavir marboxil▼ and to discuss the potential impact on patients, households and communities.
Infectious Disease Influenza Virus Infection OPTIONS-2024

Sign up or login to unlock the full suite of MEDICALLY features
Oct 15 / Roche
Patients: clinical management of influenza in children and adolescents in China
This symposium provides an overview of the latest evidence from clinical studies and real-word settings for the treatment, prevention and reduction of the transmission of influenza with baloxavir marboxil▼ and to discuss the potential impact on patients, households and communities.
Infectious Disease Influenza Virus Infection OPTIONS-2024

Sign up or login to unlock the full suite of MEDICALLY features
Oct 15 / Roche
Households: protect people by reducing transmission
This symposium provides an overview of the latest evidence from clinical studies and real-word settings for the treatment, prevention and reduction of the transmission of influenza with baloxavir marboxil▼ and to discuss the potential impact on patients, households and communities.
Infectious Disease Influenza Virus Infection OPTIONS-2024

Sign up or login to unlock the full suite of MEDICALLY features
Sep 30 / Roche and Genentech
Phase III CENTERSTONE study of single-dose baloxavir marboxil▼ for the reduction of transmission of influenza in households
This presentation provides a summary of the topline results of the CENTERSTONE study investigating the clinical efficacy of baloxavir marboxil▼ for the reduction of direct transmission of influenza from otherwise-healthy index patients to household contacts.
Infectious Disease Influenza Virus Infection OPTIONS-2024

Sign up or login to unlock the full suite of MEDICALLY features
May 22 / Roche and Genentech
Baloxavir marboxil▼ single-dose treatment in otherwise-healthy children aged <1 year with influenza: results of a single-arm, open-label study (miniSTONE-1)
miniSTONE-1 oral presentation.
Infectious Disease Influenza Virus Infection ESPID-2024

Sign up or login to unlock the full suite of MEDICALLY features
May 22 / Roche and Genentech
Baloxavir marboxil▼ for the treatment of uncomplicated influenza in children aged <1 year: population pharmacokinetic analysis and exposure matching for extrapolation of efficacy
miniSTONE-1 popPK poster.
Infectious Disease Influenza Virus Infection ESPID-2024
Upcoming Congress
Access to Roche and Genentech's latest medical information
View related congresses

Ask a question or share feedback

Get in touch

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.